229results about How to "Avoid weight gain" patented technology

A structure holds a display panel arranged inside a cabinet from the both sides by means of a holding member and a frame portion, which are supported by the circumferential surface section, so as to reduce thickness and frame width without using a bezel and to ensure rigidity. The cabinet is provided with a frame portion positioned on the display surface side of the display panel, a circumferential surface portion positioned at the periphery of the display panel, and a rear surface portion covering the other surface side of the display panel. A protruding section is arranged on the outer circumference side of the periphery of the display panel and the holding member to extend from the display surface side of the display panel toward the side opposite to the display surface, on an inner surface of the frame portion. A reinforcing section is arranged for connecting the inner circumference section of the protruding section with the inner surface section of a frame portion. The protruding section is provided with connecting sections, which are integrally formed with the inner surface of the frame portion, annularly arranged on the outer circumference of the display panel, and integrally formed at a plurality of positions on the protruding section in the circumference direction. The holding member has a section to be connected with the connecting section.

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes and associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

The invention provides glucagon analogue peptides and their use for promoting weight loss or preventing weight gain, and the treatment of obesity or excess body weight and associated conditions. The compounds may also be used to improve glycemic control and / or for the treatment of diabetes. The compounds may mediate their effect, inter alia, by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

The invention provides materials and methods for promoting weight loss or preventing weight gain without affecting glycemic control. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the glucagon-like peptide-1 (GLP-1) receptor as compared to human glucagon.

Compositions having an effective amount of a Sea Buckthorn extract and an inert carrier and methods of use therefor are disclosed and described. Such methods of use include may include controlling serum lipid concentrations in a subject, and controlling the body weight of a subject, among others.

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

Provided is a vehicle periphery alert device which is mounted on a vehicle and which operates when the vehicle reverses from a parked state. The vehicle periphery alert device comprises: a sensing means for sensing a position and a progress direction of another vehicle which is present to the rear of the vehicle; an alert operation activation means for carrying out a prescribed alert operation in the vehicle; and a control means for setting a virtual alert range to the rear of the vehicle according to an angle formed by the progress direction of the vehicle and the progress direction of the other vehicle, and for operating the alert operation activation means when a condition including the position of the other vehicle being in the set alert region is satisfied.

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.